Cargando…
The Current Status of Neuroprotection in Congenital Heart Disease
Neurological deficits are a serious and common sequelae of congenital heart disease (CHD). While their underlying mechanisms have not been fully characterized, their manifestations are well-known and understood to persist through adulthood. Development of therapies to address or prevent these defici...
Autores principales: | Kobayashi, Kei, Liu, Christopher, Jonas, Richard A., Ishibashi, Nobuyuki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8700367/ https://www.ncbi.nlm.nih.gov/pubmed/34943311 http://dx.doi.org/10.3390/children8121116 |
Ejemplares similares
-
Neuroprotection for Stroke: Current Status and Future Perspectives
por: Minnerup, Jens, et al.
Publicado: (2012) -
Neuroprotection in acute ischemic stroke – current status
por: Auriel, E, et al.
Publicado: (2010) -
The role of stents in the treatment of congenital heart disease: Current status and future perspectives
por: Peters, Bjoern, et al.
Publicado: (2009) -
Current diagnosis and treatments for critical congenital heart defects
por: ZENG, ZHANDONG, et al.
Publicado: (2016) -
Neuroprotective Therapy in Parkinson's Disease: Current Status and New Directions from Experimental and Genetic Clues
por: Lin, William, et al.
Publicado: (2005)